Leiner Settles DOJ Probe Into Drug Plant Violations

Law360, New York (May 12, 2008, 12:00 AM EDT) -- Bankrupt vitamin producer Leiner Health Products Inc. has reached a tentative settlement with U.S. investigators over alleged deficiencies in the over-the-counter drugs manufactured at the company's South Carolina plant.

Leiner Health Products said Friday it would plead guilty to one count of mail fraud and forfeit $10 million to settle a U.S. Department of Justice probe into the production, control and distribution of certain over-the-counter drug products at the now-defunct plant in Fort Mill, S.C.

The FDA issued a warning to Leiner in August after an...
To view the full article, register now.